FI52851C - Menetelmä uusien terapeuttisesti käytettävien peptidiantibioottien S 7 481/F-1 ja S 7481/F-2 valmistamiseksi. - Google Patents

Menetelmä uusien terapeuttisesti käytettävien peptidiantibioottien S 7 481/F-1 ja S 7481/F-2 valmistamiseksi.

Info

Publication number
FI52851C
FI52851C FI743434A FI343474A FI52851C FI 52851 C FI52851 C FI 52851C FI 743434 A FI743434 A FI 743434A FI 343474 A FI343474 A FI 343474A FI 52851 C FI52851 C FI 52851C
Authority
FI
Finland
Prior art keywords
preparation
therapeutically useful
peptide antibiotics
useful peptide
novel therapeutically
Prior art date
Application number
FI743434A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI343474A (xx
FI52851B (xx
Inventor
Eugen Haerri
Artur Rueegger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25713544&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI52851(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CH1711173A external-priority patent/CH589716A5/de
Priority claimed from CH1404374A external-priority patent/CH603790A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI343474A publication Critical patent/FI343474A/fi
Priority to FI771201A priority Critical patent/FI54606C/fi
Application granted granted Critical
Publication of FI52851B publication Critical patent/FI52851B/fi
Publication of FI52851C publication Critical patent/FI52851C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/06—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from fungi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/885—Trichoderma

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI743434A 1973-12-06 1974-11-27 Menetelmä uusien terapeuttisesti käytettävien peptidiantibioottien S 7 481/F-1 ja S 7481/F-2 valmistamiseksi. FI52851C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI771201A FI54606C (fi) 1973-12-06 1977-04-15 Foerfarande foer framstaellning av de nya peptidantibiotika s 7481/f-1 och s 7481/f-2

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1711173A CH589716A5 (en) 1973-12-06 1973-12-06 Antibiotics S 7481-F-1 and 2 - prepd. from new strains of Cylindrocarbon or Trichoderma esp. useful as immunosuppressant
CH1404374A CH603790A5 (en) 1974-10-21 1974-10-21 Antibiotics S 7481-F-1 and 2

Publications (3)

Publication Number Publication Date
FI343474A FI343474A (xx) 1975-06-07
FI52851B FI52851B (xx) 1977-08-31
FI52851C true FI52851C (fi) 1977-12-12

Family

ID=25713544

Family Applications (2)

Application Number Title Priority Date Filing Date
FI743434A FI52851C (fi) 1973-12-06 1974-11-27 Menetelmä uusien terapeuttisesti käytettävien peptidiantibioottien S 7 481/F-1 ja S 7481/F-2 valmistamiseksi.
FI771201A FI54606C (fi) 1973-12-06 1977-04-15 Foerfarande foer framstaellning av de nya peptidantibiotika s 7481/f-1 och s 7481/f-2

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI771201A FI54606C (fi) 1973-12-06 1977-04-15 Foerfarande foer framstaellning av de nya peptidantibiotika s 7481/f-1 och s 7481/f-2

Country Status (19)

Country Link
JP (1) JPS5615235B2 (xx)
AU (1) AU500889B2 (xx)
CA (1) CA1030469A (xx)
DD (1) DD115695A5 (xx)
DE (2) DE2455859C2 (xx)
DK (1) DK136780B (xx)
ES (1) ES432559A1 (xx)
FI (2) FI52851C (xx)
FR (1) FR2253531B1 (xx)
GB (1) GB1491509A (xx)
HK (1) HK53880A (xx)
IE (1) IE40549B1 (xx)
IL (1) IL46180A (xx)
MY (1) MY8100203A (xx)
NL (1) NL179220C (xx)
NO (1) NO744292L (xx)
NZ (1) NZ176117A (xx)
PH (1) PH13773A (xx)
SE (1) SE423720B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH614931A5 (xx) 1975-11-04 1979-12-28 Sandoz Ag
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
SE448386B (sv) * 1978-10-18 1987-02-16 Sandoz Ag Nya cyklosporinderivat, forfarande for framstellning av dem samt farmaceutisk komposition innehallande dem
US4396542A (en) 1980-02-14 1983-08-02 Sandoz Ltd. Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
ATE43335T1 (de) * 1980-02-14 1989-06-15 Sandoz Ag Peptide die einen (1s,2r,3r)- oder (1r,2s,3s)-1nitrilo-1-carbonyl-3-methyl-2-oxyheptan oder hept-5-en-rest enthalten brauchbar in totaler synsthese von cyclosporinen, und verfahren zu ihrer herstellung.
DE3260468D1 (en) 1981-01-09 1984-09-06 Sandoz Ag Novel cyclosporins
JPS59129920U (ja) * 1983-02-16 1984-08-31 日立造船株式会社 ゲ−ト付バイパスバルブの開閉操作装置
GB8717300D0 (en) * 1987-07-22 1987-08-26 Nat Res Dev Cyclosporins
FI111730B (fi) 1990-11-02 2003-09-15 Novartis Ag Menetelmä ei-immunosuppressiivisen syklosporiinin valmistamiseksi
ATE158022T1 (de) * 1991-01-25 1997-09-15 Fujisawa Pharmaceutical Co Prozess zur produktion von cyclosporin-a und/oder c
KR100304324B1 (ko) * 1994-10-13 2001-11-22 김용규 사이클로스포린a의제조방법
RU2158601C2 (ru) 1994-11-03 2000-11-10 Новартис Аг Новые лекарственные формы циклоспорина для орального применения с простым составом и высокой биодоступностью и способ их получения
US6423233B1 (en) 2000-08-15 2002-07-23 Biogal Gyogyszergyar Rt. Purification process
AU2004222306A1 (en) 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
US7511013B2 (en) 2004-09-29 2009-03-31 Amr Technology, Inc. Cyclosporin analogues and their pharmaceutical uses
EP1809656A4 (en) 2004-09-29 2009-03-25 Amr Technology Inc CYCLOSPORINAL KINANALOGA AND ITS PHARMACEUTICAL APPLICATIONS
WO2006041631A2 (en) 2004-10-06 2006-04-20 Amr Technology, Inc. Novel cyclosporin alkynes and their utility as pharmaceutical agents
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
EP2151450A1 (de) * 2008-07-29 2010-02-10 Sandoz AG Verfahren zur Aufarbeitung von mikrobiologisch hergestellten zyklischen Oligopeptiden

Also Published As

Publication number Publication date
CA1030469A (en) 1978-05-02
JPS5615235B2 (xx) 1981-04-09
MY8100203A (en) 1981-12-31
DE2463138C2 (de) 1984-07-05
SE423720B (sv) 1982-05-24
DK136780B (da) 1977-11-21
AU500889B2 (en) 1979-06-07
FI343474A (xx) 1975-06-07
FR2253531A1 (xx) 1975-07-04
ES432559A1 (es) 1977-03-01
DK136780C (xx) 1978-05-01
NZ176117A (en) 1981-05-01
FI52851B (xx) 1977-08-31
SE7415027L (xx) 1975-06-09
AU7608174A (en) 1976-06-10
DE2455859C2 (de) 1983-12-15
IE40549B1 (en) 1979-06-20
IE40549L (en) 1975-06-06
DE2455859A1 (de) 1975-06-12
DD115695A5 (xx) 1975-10-12
NL7415682A (nl) 1975-06-10
FR2253531B1 (xx) 1978-07-21
FI771201A (xx) 1977-04-15
JPS5089598A (xx) 1975-07-18
NL179220B (nl) 1986-03-03
IL46180A (en) 1978-07-31
GB1491509A (en) 1977-11-09
NO744292L (xx) 1975-06-30
IL46180A0 (en) 1975-03-13
NL179220C (nl) 1986-08-01
DK617074A (xx) 1975-07-28
FI54606C (fi) 1979-01-10
FI54606B (fi) 1978-09-29
PH13773A (en) 1980-09-23
HK53880A (en) 1980-10-03

Similar Documents

Publication Publication Date Title
FI52851C (fi) Menetelmä uusien terapeuttisesti käytettävien peptidiantibioottien S 7 481/F-1 ja S 7481/F-2 valmistamiseksi.
CA981021A (en) Glass ceramic material
CA967368A (en) Glass ceramic material
CA979023A (en) Monolithic refractory materials
CA1011189A (en) Refractory materials
CA1023912A (en) Preparation of fibres from polymeric materials
CA980367A (en) Ceramic material
CA1024130A (en) Ceramic materials
SE424994B (sv) Forfarande for framstellning av nya pseudotrisackarider
SE416731B (sv) Forfarande for framstellning av nya penicilliner
ATA392073A (de) Verbindungsvorrichtung zur losbaren befestigung eines tragbalkens an einem steher
NO139522C (no) Fremgangsmaate til fremstilling av deoksyamino-glycosid-antibiotika
CA990739A (en) Refractories
AU466331B2 (en) Preparation of n-(1-ethyl-pyrrolidylmethyl)-2-methoxy-5-sulfonamidobenzamide
NO139864C (no) B fremgangsmaate til fremstilling av antibiotikum fortimicin
SE7608016L (sv) Forfarande for framstellning av nya antibiotika benemnda a 28695 a och a 28695 b
AU4671572A (en) Pharmaceutical intermediates
CA1012044A (en) Interferon assay
CA976974A (en) Preparation of n-(1-ethyl-2-pyrrolidylmethyl)-2-methoxy-5-ethylsulphonyl-benzamide
AU477307B2 (en) Novel intermediates for preparing semisynthetic penicillins and cephalosporins and processes relating thereto
FI50411C (fi) Menetelmä aryyliamino-2-imidatsoliinien valmistamiseksi
FI47482C (fi) Analogiamenetelmä uusien, tulehdusta estävästi ja gestageenisesti vaik uttavien 6-halogeeni-21-fluori-3,16,17-trihydroksipregna-4,6-dieeni-20 -onijohdannaisten valmistamiseksi.
FI52583C (fi) Menetelmä uusien terapeuttisesti tehokkaiden 4H-s-triatsolo(4,3-a)(1,4 )-bentsotiatsepiini-1-karboksialdehydi-dialkyyliasetaalien valmistamis eksi.
CA867355A (en) Process for the preparation of biologically active polypeptides
AU478495B2 (en) Ceramic materials